Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer | MRK Stock NewsStockTitan·2 days ago, 04:00 AMREGN+0.63%
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancerPUBT·2 days ago, 03:11 PMRVMD+0.25%
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSSPR Newswire·Jul 21 at 06:00 PMREGN+0.63%
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSSprnewswire·Jul 21 at 03:28 PMERAS-1.19%RVMD+0.25%
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price TargetTip Ranks·2 days ago, 04:35 PMRVMD+0.25%
REGN Breaking News: Regeneron Inc. Sued for Securities Fraud after Revealing Failed Phase III Clinical Trial Resulting in 10% Stock Drop – Investors Notified to Contact BFA LawMorningStar·Jul 21 at 03:14 PMREGN+0.63%
Gilead, Merck Advance Potential Blockbuster Weekly HIV Pillbenzinga_article·Jul 21 at 12:28 PMMRK+0.45%GIS
Gilead posts press release on once-weekly oral HIV regimen trial resultsPUBT·Jul 21 at 09:01 AMGILD-1.18%GIS
Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfoliobenzinga_article·Jul 20 at 04:11 PMMRK+0.45%AMGN+1.22%
GSK notifies availability of ViiV Healthcare AIDS 2026 data presentation announcementPUBT·Jul 21 at 03:01 AMGSK+1.20%GSK
Amgen Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsMarketWatch Automated·12 hours agoAMGN+1.22%
Florida Financial Advisors LLC Decreases Stock Holdings in Gilead Sciences, Inc. $GILDMarket Beat·2 days ago, 04:20 AMGILD-1.18%GIS
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?benzinga_article·22 hours agoAMPH-0.79%ANIP-1.12%
